An area of IP that is too often overlooked is that of IP strategy. A company with some level of IP – and every company does have some! – should invest a little time in thinking through their IP strategy. Otherwise the likelihood is that the decisions regarding IP are made without sufficient regard to what the realistic objectives […]

Do you only ever think of trade marks being words or pictures? Actually the possibilities are much, much wider. Essentially a trade mark is any “sign” capable of distinguishing your goods or services from those of any other trader. So, for instance, a trade mark can include a shape.

Nagoya – What every UK Biotech company should know The Nagoya Protocol is here to stay and its requirements will fundamentally affect biotech research in the UK.

Intellectual Property is central to protecting the ideas, creativity and brands. But many businesses fail to take action to protect such valuable assets. Their reason? There’s no point, we wouldn’t be able to afford a court action to stop an infringer anyway.

The USPTO has issued new Guidelines for US Examiners to use in order to determine whether an invention is patent eligible (i.e. is of a type which is not barred from being patentable). These Guidelines are effective from 16 December 2014 and address concerns raised following the US PTO’s change in practice (subsequent to recent biotech Supreme Court patent […]